MS in the media - 7 October 2015
These are links to recent news stories that may be of interest to people in the UK. The link beneath each item will take you to the original story.
Please note that the MS Trust did not write the original items and does not endorse their content nor any claims made in them.
To keep up to date on all the latest news, views and research on multiple sclerosis, sign up for Open Door, our free newsletter or regular email alerts.
Woman of the Year award for woman with MS
Trishna Bharadia has been given a Woman of the Year award for her work raising awareness of MS. This year she also took part in the People's Strictly for Comic Relief
Source: Nottingham Post
MS Trust link: Jiving and managing MS symptoms - on the People’s Strictly
Aubagio and atrophy
People with relapsing remitting MS taking Aubagio (teriflunomide) showed slower loss of brain tissue over two years than a placebo group.
Source: Genzyme press release
MS Trust link: Aubagio (teriflunomide)
New MS centre opens in Stoke
The Royal Stoke University Hospital has set up a new MS centre of excellence to provide better care and swifter diagnosis for people with MS
Source: Stoke Sentinel
MS Trust link: Newly diagnosed with multiple sclerosis
MS won’t stop me showjumping
18 February 2019
When Laura Goodall was diagnosed with MS in 2015, she thought her showjumping days might be over. But, four years later, Laura is back competing across the country and has recently been accepted onto the British Showjumping Para team.
MS won’t stop me showjumping
18 February 2019
When Laura Goodall was diagnosed with MS in 2015, she thought her showjumping days might be over. But, four years later, Laura is back competing across the country and has recently been accepted onto the British Showjumping Para team.
MS in the Media
15 February 2019
- People with MS have poorer social cognition
- Carer strain increases with disability
Sign up to our emails
Get the latest news and research sent straight to your inbox. Find out first about the latest developments in MS treatments, plus updates on the work of the MS Trust.
Share
